Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America

個数:1
紙書籍版価格
¥26,637
  • 電子書籍
  • ポイントキャンペーン

Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America

  • 著者名:Graham MD, Camilla S./Trooskin MD, PhD, Stacey B.
  • 価格 ¥47,690 (本体¥43,355)
  • Elsevier(2018/05/23発売)
  • 春分の日の三連休!Kinoppy 電子書籍・電子洋書 全点ポイント30倍キャンペーン(~3/22)
  • ポイント 12,990pt (実際に付与されるポイントはご注文内容確認画面でご確認下さい)
  • 言語:ENG
  • ISBN:9780323584036
  • eISBN:9780323584043

ファイル: /

Description

The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analysis of solutions to specific challenges faced in the United States and globally in implementing HCV elimination strategies. They believe that clinicians now have the tools and road maps needed to accomplish this goal. The clinical review articles in this issue accomplish that: Using Existing Health Care Infrastructure To Expand HCV Care; Creating A Reproducible Health Economic Model To Describe The Burden Of HCV And Cost Of Treatment In Any Country; The Best Uses Of Cost-Effectiveness Models In HCV; Increasing Access To HCV Care In Corrections; Cure As Prevention Strategies For HCV In People Who Inject Drugs; Australia Will Eliminate HCV – How It Works; New York Is The First State In The US To Develop An HCV Elimination Strategy; When HCV Diagnostics Are The Barrier To Care; Key Findings From The Checs HCV Cohort Study; Strategies To Reduce HCV Reinfection Rates In People Who Inject Drugs; Strategies To Reduce HCV Reinfection Rates In Men Who Have Sex With Other Men; The Value Of Curing HCV From A Payer's Perspective; How To Expand Care Capacity In HCV; Strategies To Eliminate HCV In The HIV Coinfected Population; and The US Veteran's Administration: Lessons Learned And Best Practices For HCV Elimination.

Table of Contents

Preface: Removing the Barriers from the Path to Eliminate Hepatitis CLong-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current ChronicHepatitis Cohort Study Status and Review of FindingsElimination of Hepatitis C Virus in Australia: Laying the FoundationHepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success Localized US Efforts to Eliminate Hepatitis CNew Treatments Have Changed the Game: Hepatitis C Treatment in Primary CareFive Questions Concerning Managing Hepatitis C in the Justice System: FindingPractical Solutions for Hepatitis C Virus EliminationTreatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy:A Review of Best PracticeStrategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men Hepatitis C Virus Elimination in the Human Immunodeficiency Virus–CoinfectedPopulation: Leveraging the Existing Human Immunodeficiency Virus Infrastructure Hepatitis C Virus Diagnosis and the Holy GrailA Guide to the Economics of Hepatitis C Virus Cure in 2017Estimation of Hepatitis C Disease Burden and Budget Impact of TreatmentUsing Health Economic ModelingThe Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective

最近チェックした商品